Tapewire

NYSE · USD

G

Genpact LTD

Export transactions ↓
Tapewire entity
3760
SEC CIK
0001398659
Parsed reports
457

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202602
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202606
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 21, 2020 Filed Jan 23, 2020 21:15 UTC
Tyagarajan N. V.Director · President and CEO
Tax withholdingCommon Shares 47,778 $43.49 $2,077,865.22
Disclosure

SEC source: 0001567619-20-001447 · doc1.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,113

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 30, 2017 under the Genpact Limited 2007 Omnibus Incentive Compensation Plan

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:13 UTC
Mazhari AhmedSenior Vice President
Tax withholdingCommon Shares 39,258 $43.49 $1,707,330.42
Disclosure

SEC source: 0001567619-20-001445 · doc1.xml · nonDerivative · entry 1

Mazhari Ahmed · CIK 0001768278 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,979

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 30, 2017 under the Genpact Limited 2007 Omnibus Incentive Compensation Plan.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:12 UTC
Kalra BalkrishanSenior Vice President
Tax withholdingCommon Shares 31,766 $43.49 $1,381,503.34
Disclosure

SEC source: 0001567619-20-001444 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,250

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 30, 2017 under the Genpact Limited 2007 Omnibus Incentive Compensation Plan.

Read SEC document
January 21, 2020 Filed Jan 23, 2020 21:08 UTC
White HeatherSVP & General Counsel
Tax withholdingCommon Shares 6,418 $43.49 $279,118.82
Disclosure

SEC source: 0001567619-20-001441 · doc1.xml · nonDerivative · entry 1

White Heather · CIK 0001736502 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,395

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of performance share units granted on May 9, 2017 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

F2 · balance_after: Includes 280 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on June 15, 2019. The reporting person currently holds a total of 622 shares under the ESPP.

Read SEC document
December 06, 2019 Filed Dec 10, 2019 21:06 UTC
Mazhari AhmedSenior Vice President
SaleCommon Shares 6,000 $40.65 $243,907.20
Disclosure

SEC source: 0001567619-19-022824 · doc1.xml · nonDerivative · entry 1

Mazhari Ahmed · CIK 0001768278 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,237

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.6432 to $40.6566. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
December 04, 2019 Filed Dec 6, 2019 16:07 UTC
Cogny PatrickSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-022719 · doc1.xml · derivative · entry 3

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 30,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
December 04, 2019 Filed Dec 6, 2019 16:07 UTC
Cogny PatrickSenior Vice President
SaleCommon Shares 30,000 $40.12 $1,203,726.00
Disclosure

SEC source: 0001567619-19-022719 · doc1.xml · nonDerivative · entry 2

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,026

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.10 to $40.145. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
December 04, 2019 Filed Dec 6, 2019 16:07 UTC
Cogny PatrickSenior Vice President
Exercise / conversionCommon Shares 30,000 $19.35 $580,500.00
Disclosure

SEC source: 0001567619-19-022719 · doc1.xml · nonDerivative · entry 1

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2019 Filed Dec 2, 2019 21:15 UTC SaleCommon Shares 5,000 $41.03 $205,166.00
Disclosure

SEC source: 0001567619-19-022456 · doc1.xml · nonDerivative · entry 1

Lindstrom Carol · CIK 0001677400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,467

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.905 to $41.075. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 26, 2019 Filed Nov 27, 2019 21:20 UTC SaleCommon Shares 12,916,004 $39.87 $514,896,499.46
Disclosure

SEC source: 0000899243-19-028231 · doc4.xml · nonDerivative · entry 1

Humphrey David · CIK 0001557605 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · ownership.nature: Represents Common Shares held directly by Glory Investment A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investment IV Limited ("Glory IV") and Glory Investment IV-B Limited ("Glory IV-B" and, together with Glory A, Glory B, and Glory IV, the "Bain Capital Entities").

F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Glory A and Glory B and governs the investment strategy and decision-making process on behalf of Glory IV and Glory IV-B. David Humphrey is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Humphrey may be deemed to share voting and dispositive power with respect to the Common Shares held by the Bain Capital Entities. Mr. Humphrey disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
November 21, 2019 Filed Nov 25, 2019 21:07 UTC GrantCommon Shares 4,455 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-022191 · doc1.xml · nonDerivative · entry 1

Cartwright Stacey · CIK 0001793588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,455

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share at a future date. Subject to the reporting person's continued service, the RSUs will vest 50% on November 21, 2021 and 50% on November 21, 2023.

Read SEC document
August 30, 2019 Filed Sep 3, 2019 20:09 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017777 · doc1.xml · derivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,280

Underlying: Common Shares · 10,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 30, 2019 Filed Sep 3, 2019 20:09 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 10,000 $40.97 $409,652.00
Disclosure

SEC source: 0001567619-19-017777 · doc1.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,016

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.950 to $41.005. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 30, 2019 Filed Sep 3, 2019 20:09 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 10,000 $19.35 $193,500.00
Disclosure

SEC source: 0001567619-19-017777 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2019 Filed Sep 3, 2019 16:06 UTC
Cogny PatrickSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017774 · doc1.xml · derivative · entry 3

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Shares · 35,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 29, 2019 Filed Sep 3, 2019 16:06 UTC
Cogny PatrickSenior Vice President
SaleCommon Shares 35,000 $40.85 $1,429,585.50
Disclosure

SEC source: 0001567619-19-017774 · doc1.xml · nonDerivative · entry 2

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,026

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.80 to $40.90. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 29, 2019 Filed Sep 3, 2019 16:06 UTC
Cogny PatrickSenior Vice President
Exercise / conversionCommon Shares 35,000 $19.35 $677,250.00
Disclosure

SEC source: 0001567619-19-017774 · doc1.xml · nonDerivative · entry 1

Cogny Patrick · CIK 0001408323 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,026

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · derivative · entry 6

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,280

Underlying: Common Shares · 20,000 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 20,000 $40.30 $805,986.00
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · nonDerivative · entry 4

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,016

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.275 to $40.335. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 20,000 $19.35 $387,000.00
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · nonDerivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,200 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · derivative · entry 5

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,280

Underlying: Common Shares · 10,200 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 10,200 $40.21 $410,154.24
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,016

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.20 to $40.25. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 20:07 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 10,200 $19.35 $197,370.00
Disclosure

SEC source: 0001567619-19-017670 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,216

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 22, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 31,701 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · derivative · entry 6

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,480

Underlying: Common Shares · 31,701 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 22, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 31,701 $40.60 $1,286,984.52
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · nonDerivative · entry 4

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,016

F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.51 to $40.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 22, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 31,701 $19.35 $613,414.35
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · nonDerivative · entry 3

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,819 $0.00 Strike: $19.35 $0.00
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · derivative · entry 5

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,181

Underlying: Common Shares · 5,819 shares

Expires 2023-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 50% on January 10, 2016 and 50% on January 10, 2018.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
SaleCommon Shares 5,819 $41.10 $239,160.90
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · nonDerivative · entry 2

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,016

Read SEC document
August 21, 2019 Filed Aug 23, 2019 20:05 UTC
Kalra BalkrishanSenior Vice President
Exercise / conversionCommon Shares 5,819 $19.35 $112,597.65
Disclosure

SEC source: 0001567619-19-017516 · doc1.xml · nonDerivative · entry 1

Kalra Balkrishan · CIK 0001768217 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 797 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 3 filed on Feb 25, 2019. The reporting person currently holds a total of 4,840 shares under the ESPP.

Read SEC document
August 16, 2019 Filed Aug 19, 2019 20:29 UTC SaleCommon Shares 10,621,804 $40.51 $430,289,280.04
Disclosure

SEC source: 0000899243-19-022042 · doc4.xml · nonDerivative · entry 1

BAIN CAPITAL INVESTORS LLC · CIK 0001040508 · 10% owner

Bain Capital Partners Asia II, L.P. · CIK 0001520731 · 10% owner

Bain Capital Partners X, L.P. · CIK 0001525871 · 10% owner

BCIP Associates IV, L.P. · CIK 0001561353 · 10% owner

BCIP Associates IV-B, L.P. · CIK 0001561352 · 10% owner

Glory Investments A Ltd · CIK 0001561186 · 10% owner

Glory Investments B Ltd · CIK 0001561183 · 10% owner

Glory Investments IV Ltd · CIK 0001561182 · 10% owner

Glory Investments IV-B Ltd · CIK 0001561181 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 12,916,004

F1 · ownership.nature: Bain Capital Partners Asia II, L.P. ("Asia II") is the Class A shareholder of Glory Investments A Limited ("Glory A"). As a result, Asia II may be deemed to beneficially own Common Shares held by Glory A. Asia II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On August 16, 2019, Glory A sold 2,957,962 Common Shares. Following such sale, Glory A held 3,596,840 Common Shares.

F2 · ownership.nature: Bain Capital Partners X, L.P. ("BCP X") is the Class A shareholder of Glory Investments B Limited ("Glory B"). As a result, BCP X may be deemed to beneficially own Common Shares held by Glory B. BCP X disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On August 16, 2019, Glory B sold 7,293,590 Common Shares. Following such sale, Glory B held 8,868,930 Common Shares

F3 · ownership.nature: On August 16, 2019, Glory Investments IV Limited ("Glory IV"), whose Class A shareholder is BCIP Associates IV, L.P. ("BCIP IV"), whose general partner is Boylston Coinvestors, LLC ("Boylston"), sold 344,326 Common Shares. Following such sale, Glory IV held 418,700 Common Shares. BCIP IV may be deemed to beneficially own Common Shares held by Glory IV. BCIP IV disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F4 · ownership.nature: On August 16, 2019, Glory Investments IV-B Limited ("Glory IV-B" and together with Glory A, Glory B and Glory IV, the "Bain Capital Entities"), whose Class A shareholder is BCIP Associates IV-B, L.P. ("BCIP IV-B"), whose general partner is Boylston, sold 25,926 shares of Common Stock. Following such sale, Glory IV-B held 31,534 Common Shares. BCIP IV-B may be deemed to beneficially own Common Shares held by Glory IV-B. BCIP IV-B disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F5 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Asia II and BCP X and governs the investment strategy and decision-making process with respect to investments held by Glory IV and Glory IV-B.

F6 · ownership.nature: By virtue of the relationships described in these footnotes, BCI may be deemed to share voting and dispositive power with respect to the Common Shares held by the Bain Capital Entities. BCI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Read SEC document
August 16, 2019 Filed Aug 19, 2019 20:49 UTC
GIC Private LtdSee Remarks
SaleCommon Shares, par value $0.01 per share 1,878,196 $40.51 $76,085,719.96
Disclosure

SEC source: 0000899243-19-022053 · doc4.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · See Remarks

Twickenham Investment Private Ltd · CIK 0001561359 · See Remarks

GIC Special Investments Pte Ltd · CIK 0001296212 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,514,837

F1 · balance_after: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · balance_after: On August 13, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Goldman Sachs & Co. LLC (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,878,196 common shares of the Issuer from Twickenham at a price of $40.51 per share. This transaction closed on August 16, 2019.

F3 · balance_after: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 2,283,862 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 2,283,862 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · balance_after: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · balance_after: Pursuant to the Investor Agreement, as amended on May 24, 2019, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · balance_after: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · balance_after: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F1 · ownership.direct: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · ownership.direct: On August 13, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Goldman Sachs & Co. LLC (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,878,196 common shares of the Issuer from Twickenham at a price of $40.51 per share. This transaction closed on August 16, 2019.

F3 · ownership.direct: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 2,283,862 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 2,283,862 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · ownership.direct: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · ownership.direct: Pursuant to the Investor Agreement, as amended on May 24, 2019, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · ownership.direct: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · ownership.direct: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F1 · ownership.nature: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · ownership.nature: On August 13, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Goldman Sachs & Co. LLC (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,878,196 common shares of the Issuer from Twickenham at a price of $40.51 per share. This transaction closed on August 16, 2019.

F3 · ownership.nature: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 2,283,862 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 2,283,862 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · ownership.nature: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · ownership.nature: Pursuant to the Investor Agreement, as amended on May 24, 2019, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · ownership.nature: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · ownership.nature: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Read SEC document
August 16, 2019 Filed Aug 19, 2019 20:22 UTC SaleCommon Shares 10,621,804 $40.51 $430,289,280.04
Disclosure

SEC source: 0000899243-19-022037 · doc4.xml · nonDerivative · entry 1

Humphrey David · CIK 0001557605 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 12,916,004

F1 · ownership.nature: Represents Common Shares held directly by Glory Investment A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investment IV Limited ("Glory IV") and Glory Investment IV-B Limited ("Glory IV-B" and, together with Glory A, Glory B, and Glory IV, the "Bain Capital Entities").

F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Glory A and Glory B and governs the investment strategy and decision-making process on behalf of Glory IV and Glory IV-B. David Humphrey is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Humphrey may be deemed to share voting and dispositive power with respect to the Common Shares held by the Bain Capital Entities. Mr. Humphrey disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:16 UTC
White HeatherSVP & General Counsel
SaleCommon Shares 1,058 $36.08 $38,176.03
Disclosure

SEC source: 0001567619-19-012824 · doc1.xml · nonDerivative · entry 1

White Heather · CIK 0001736502 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,533

F1 · balance_after: Includes 342 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on February 21, 2019. The reporting person currently holds a total of 342 shares under the ESPP.

Read SEC document
May 24, 2019 Filed May 28, 2019 21:17 UTC SaleCommon Shares 8,500,194 $36.01 $306,091,985.94
Disclosure

SEC source: 0000899243-19-014886 · doc4.xml · nonDerivative · entry 1

BAIN CAPITAL INVESTORS LLC · CIK 0001040508 · 10% owner

Bain Capital Partners Asia II, L.P. · CIK 0001520731 · 10% owner

Bain Capital Partners X, L.P. · CIK 0001525871 · 10% owner

BCIP Associates IV, L.P. · CIK 0001561353 · 10% owner

BCIP Associates IV-B, L.P. · CIK 0001561352 · 10% owner

Glory Investments A Ltd · CIK 0001561186 · 10% owner

Glory Investments B Ltd · CIK 0001561183 · 10% owner

Glory Investments IV Ltd · CIK 0001561182 · 10% owner

Glory Investments IV-B Ltd · CIK 0001561181 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 23,537,808

F1 · ownership.nature: Bain Capital Partners Asia II, L.P. ("Asia II") is the Class A shareholder of Glory Investments A Limited ("Glory A"). As a result, Asia II may be deemed to beneficially own Common Shares held by Glory A. Asia II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On May 24, 2019, Glory A sold 2,367,136 Common Shares. Following such sale, Glory A held 6,554,802 Common Shares.

F2 · ownership.nature: Bain Capital Partners X, L.P. ("BCP X") is the Class A shareholder of Glory Investments B Limited ("Glory B"). As a result, BCP X may be deemed to beneficially own Common Shares held by Glory B. BCP X disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On May 24, 2019, Glory B sold 5,836,760 Common Shares. Following such sale, Glory B held 16,162,520 Common Shares.

F3 · ownership.nature: On May 24, 2019, Glory Investments IV Limited ("Glory IV"), whose Class A shareholder is BCIP Associates IV, L.P. ("BCIP IV"), whose general partner is Boylston Coinvestors, LLC ("Boylston"), sold 275,550 Common Shares. Following such sale, Glory IV held 763,026 Common Shares. BCIP IV may be deemed to beneficially own Common Shares held by Glory IV. BCIP IV disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F4 · ownership.nature: On May 24, 2019, Glory Investments IV-B Limited ("Glory IV-B" and together with Glory A, Glory B and Glory IV, the "Bain Capital Entities"), whose Class A shareholder is BCIP Associates IV-B, L.P. ("BCIP IV-B"), whose general partner is Boylston, sold 20,748 shares of Common Stock. Following such sale, Glory IV-B held 57,460 Common Shares. BCIP IV-B may be deemed to beneficially own Common Shares held by Glory IV-B. BCIP IV-B disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F5 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Asia II and BCP X and governs the investment strategy and decision-making process with respect to investments held by Glory IV and Glory IV-B.

F6 · ownership.nature: By virtue of the relationships described in these footnotes, BCI may be deemed to share voting and dispositive power with respect to the Common Shares held by the Bain Capital Entities. BCI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein

Read SEC document
May 24, 2019 Filed May 28, 2019 21:28 UTC
GIC Private LtdSee Footnotes
SaleCommon Shares, par value $0.01 per share 1,499,806 $36.01 $54,008,014.06
Disclosure

SEC source: 0000899243-19-014894 · doc4.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · See Footnotes

Twickenham Investment Private Ltd · CIK 0001561359 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,393,033

F1 · balance_after: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · balance_after: On May 21, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Citigroup Global Markets Inc. (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,499,806 common shares of the Issuer from Twickenham at a price of $36.01 per share. This transaction closed on May 24, 2019.

F3 · balance_after: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 4,162,058 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 4,162,058 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · balance_after: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · balance_after: Pursuant to the Investor Agreement, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · balance_after: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · balance_after: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F1 · ownership.direct: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · ownership.direct: On May 21, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Citigroup Global Markets Inc. (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,499,806 common shares of the Issuer from Twickenham at a price of $36.01 per share. This transaction closed on May 24, 2019.

F3 · ownership.direct: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 4,162,058 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 4,162,058 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · ownership.direct: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · ownership.direct: Pursuant to the Investor Agreement, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · ownership.direct: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · ownership.direct: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F1 · ownership.nature: This report is filed jointly by GIC Private Limited ("GIC"), GIC Special Investments Pte. Ltd. ("GICSI") and Twickenham Investment Private Limited ("Twickenham", and together with GIC and GICSI, the "Reporting Persons").

F2 · ownership.nature: On May 21, 2019, Twickenham entered into an underwriting agreement (the "Underwriting Agreement") with the Issuer, Citigroup Global Markets Inc. (the "Underwriter") and various other selling shareholders named therein, pursuant to which the Underwriter agreed to purchase an aggregate of 1,499,806 common shares of the Issuer from Twickenham at a price of $36.01 per share. This transaction closed on May 24, 2019.

F3 · ownership.nature: GIC is the direct owner of 230,975 common shares of the Issuer and Twickenham is the direct owner of 4,162,058 common shares of the Issuer. Twickenham is controlled and managed by GICSI, which is in turn wholly-owned by GIC. GICSI and GIC may be deemed to share voting and dispositive power with respect to the 4,162,058 common shares of the Issuer directly owned by Twickenham. No individual has beneficial ownership over the common shares of the Issuer beneficially owned by the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.

F4 · ownership.nature: On October 25, 2012, (i) Twickenham, Glory Investments A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investments IV Limited ("Glory IV"), Glory Investments IV-B Limited ("GloryIV-B"), RGIP, LLC ("RGIP" and collectively with Glory A, Glory B, Glory IV, Glory IV-B and Twickenham, the "Genpact Investors"), Glory Investments TA IV Limited ("Glory TA") and the Issuer entered into an amended and restated shareholders agreement (the "Shareholders Agreement"), and (ii) the Genpact Investors and Glory TA entered into an investor agreement ("Investor Agreement").

F5 · ownership.nature: Pursuant to the Investor Agreement, the Genpact Investors irrevocably appointed a single Investors' Representative (as defined in the Investor Agreement) as its sole and exclusive agent and proxy and true and lawful attorney-in-fact to take certain actions on behalf of each of the Genpact Investors relating to the voting and disposition of the Common Shares and the exercise of certain rights under the Shareholders Agreement, including, (i) voting and dispositive authority with respect to all Common Shares held directly or indirectly by the Genpact Investors, (ii) power to exercise registration rights under the Shareholders Agreement, (iii) the exclusive power to designate all individuals with respect to which the Genpact Investors may, by rights granted to them under the Shareholders Agreement, nominate to the Issuer's board of directors (including designation of such individuals' respective replacements), and

F6 · ownership.nature: (Continued From Footnote 5) (iv) power and authority to elect to subscribe for new equity securities of Genpact on behalf of the Genpact Investors in connection with the exercise of any pre-emptive rights of the Genpact Investors under the Shareholders Agreement.

F7 · ownership.nature: As a result of the Shareholders Agreement and Investor Agreement, each of the Genpact Investors and Glory TA may be deemed to beneficially own the Common Shares held by Twickenham, Glory A, Glory B, Glory IV and Glory IV-B. Twickenham disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Read SEC document
May 24, 2019 Filed May 28, 2019 21:32 UTC
Humphrey DavidDirector · 10% owner
SaleCommon Shares 8,500,194 $36.01 $306,091,985.94
Disclosure

SEC source: 0000899243-19-014896 · doc4.xml · nonDerivative · entry 1

Humphrey David · CIK 0001557605 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 23,537,808

F1 · ownership.nature: Represents Common Shares held directly by Glory Investment A Limited ("Glory A"), Glory Investments B Limited ("Glory B"), Glory Investment IV Limited ("Glory IV") and Glory Investment IV-B Limited ("Glory IV-B" and, together with Glory A, Glory B, and Glory IV, the "Bain Capital Entities").

F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Glory A and Glory B and governs the investment strategy and decision-making process on behalf of Glory IV and Glory IV-B. David Humphrey is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Humphrey may be deemed to share voting and dispositive power with respect to the Common Shares held by the Bain Capital Entities. Mr. Humphrey disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
May 09, 2019 Filed May 13, 2019 16:15 UTC
Agrawal AjayDirector
GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010571 · doc1.xml · nonDerivative · entry 1

Agrawal Ajay · CIK 0001765311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,874

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 16:22 UTC GrantCommon Shares 7,484 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010576 · doc1.xml · nonDerivative · entry 1

SCOTT ROBERT G · CIK 0001182531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,559

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:19 UTC GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010574 · doc1.xml · nonDerivative · entry 1

Madden James C. · CIK 0001408228 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,987

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 16:09 UTC GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-013212 · doc4.xml · nonDerivative · entry 1

NUNNELLY MARK E · CIK 0001213410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,907

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:09 UTC
Humphrey DavidDirector · 10% owner
GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-013213 · doc4.xml · nonDerivative · entry 1

Humphrey David · CIK 0001557605 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,907

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:20 UTC GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010575 · doc1.xml · nonDerivative · entry 1

Morken CeCelia · CIK 0001367198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,662

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:23 UTC
Verdi Mark ADirector
GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010577 · doc1.xml · nonDerivative · entry 1

Verdi Mark A · CIK 0001560520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,907

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:16 UTC GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010572 · doc1.xml · nonDerivative · entry 1

Conigliaro Laura · CIK 0001528935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,118

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:18 UTC GrantCommon Shares 3,326 $0.00 $0.00
Disclosure

SEC source: 0001567619-19-010573 · doc1.xml · nonDerivative · entry 1

Lindstrom Carol · CIK 0001677400 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,467

F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020.

Read SEC document
April 22, 2019 Filed Apr 24, 2019 20:03 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 133,625 $0.00 Strike: $9.52 $0.00
Disclosure

SEC source: 0001567619-19-009110 · doc1.xml · derivative · entry 4

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 133,625 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested 20% annually over 5 years beginning on May 1, 2010.

Read SEC document
April 22, 2019 Filed Apr 24, 2019 20:03 UTC
Tyagarajan N. V.Director · President and CEO
SaleCommon Shares 133,625 $35.95 $4,803,230.80
Disclosure

SEC source: 0001567619-19-009110 · doc1.xml · nonDerivative · entry 2

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 483,891

F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $35.56 to $36.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
April 22, 2019 Filed Apr 24, 2019 20:03 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionCommon Shares 133,625 $9.52 $1,272,069.91
Disclosure

SEC source: 0001567619-19-009110 · doc1.xml · nonDerivative · entry 1

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 09, 2019 Filed Apr 11, 2019 20:06 UTC
Saumur DarrenSenior Vice President
Tax withholdingCommon Shares 9,368 $35.57 $333,219.76
Disclosure

SEC source: 0001567619-19-008696 · doc1.xml · nonDerivative · entry 1

Saumur Darren · CIK 0001768292 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,386

F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

Read SEC document
April 08, 2019 Filed Apr 10, 2019 20:06 UTC
Tyagarajan N. V.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $9.52 $0.00
Disclosure

SEC source: 0001567619-19-008667 · doc1.xml · derivative · entry 4

Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,625

Underlying: Common Shares · 150,000 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.

F4 · derivative.exercise_date: The?option?vested?20%?annually?over?5?years?beginning?on May?1,?2010.

F5 · balance_after: The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.